Menu
GWAS Study

Identifying genetic factors that contribute to the increased risk of congenital heart defects in infants with Down syndrome.

Trevino CE, Holleman AM, Corbitt H et al.

33093519 PubMed ID
GWAS Study Type
487 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

TC
Trevino CE
HA
Holleman AM
CH
Corbitt H
MC
Maslen CL
RT
Rosser TC
CD
Cutler DJ
JH
Johnston HR
RB
Rambo-Martin BL
OJ
Oberoi J
DK
Dooley KJ
CG
Capone GT
RR
Reeves RH
CH
Cordell HJ
KB
Keavney BD
AA
Agopian AJ
GE
Goldmuntz E
GP
Gruber PJ
OJ
O'Brien JE
BD
Bittel DC
WL
Wadhwa L
CC
Cua CL
MI
Moskowitz IP
MJ
Mulle JG
EM
Epstein MP
SS
Sherman SL
ZM
Zwick ME
Chapter II

Abstract

Summary of the research findings

Atrioventricular septal defects (AVSD) are a severe congenital heart defect present in individuals with Down syndrome (DS) at a > 2000-fold increased prevalence compared to the general population. This study aimed to identify risk-associated genes and pathways and to examine a potential polygenic contribution to AVSD in DS. We analyzed a total cohort of 702 individuals with DS with or without AVSD, with genomic data from whole exome sequencing, whole genome sequencing, and/or array-based imputation. We utilized sequence kernel association testing and polygenic risk score (PRS) methods to examine rare and common variants. Our findings suggest that the Notch pathway, particularly NOTCH4, as well as genes involved in the ciliome including CEP290 may play a role in AVSD in DS. These pathways have also been implicated in DS-associated AVSD in prior studies. A polygenic component for AVSD in DS has not been examined previously. Using weights based on the largest genome-wide association study of congenital heart defects available (2594 cases and 5159 controls; all general population samples), we found PRS to be associated with AVSD with odds ratios ranging from 1.2 to 1.3 per standard deviation increase in PRS and corresponding liability r2 values of approximately 1%, suggesting at least a small polygenic contribution to DS-associated AVSD. Future studies with larger sample sizes will improve identification and quantification of genetic contributions to AVSD in DS.

245 European ancestry cases, 242 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

487
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.